Literature DB >> 21396100

Endothelial progenitor cells (EPC) in sepsis with acute renal dysfunction (ARD).

Susann A Patschan1, Daniel Patschan, Johanna Temme, Peter Korsten, Johannes T Wessels, Michael Koziolek, Elvira Henze, Gerhard A Müller.   

Abstract

INTRODUCTION: Sepsis is characterized by systemic microvascular dysfunction. Endothelial progenitor cells (EPCs) are critically involved in maintaining vascular homeostasis under both physiological and pathological conditions. The aim of the present study was to analyze the endothelial progenitor cell system in patients suffering from sepsis with acute renal dysfunction.
METHODS: Patients with newly diagnosed sepsis were recruited from the ICU in a nonrandomized prospective manner. Blood samples were obtained within the first 12 hours after the diagnosis of sepsis. For quantifying endothelial progenitor cells (EPCs), CD133+/Flk-1+ cells were enumerated by cytometric analysis. Analysis of EPC proliferation was performed by a colony-forming units (CFU) assay. Blood concentrations of proangiogenic mediators were measured by ELISA. Acute renal dysfunction was diagnosed according to the Acute Kidney Injury Network (AKIN) criteria. Depending on the overall mean creatinine concentration during the stay at the ICU, patients were either assigned to a 'normal creatinine group' or to a 'high creatinine group'. Survival rates, frequency of dialysis, the simplified acute physiology score (SAPS) II scores, and different laboratory parameters were collected/used for further clinical characterization
RESULTS: Circulating EPCs were significantly higher in all sepsis patients included in the study as opposed to healthy controls. Patients within the 'high creatinine group' showed an even more pronounced EPC increase. In contrast, EPC proliferation was severely affected in sepsis. Neither total circulating EPCs nor EPC proliferation differed between patients requiring dialysis and patients without renal replacement therapy. Cell numbers and cell proliferation also did not differ between surviving patients and patients with sepsis-related death. Serum levels of vascular endothelial growth factor (VEGF), stromal derived factor-1 (SDF-1), and Angiopoietin-2 were higher in sepsis than in healthy controls. Sepsis patients within the 'high creatinine group' showed significantly higher mean serum levels of uric acid.
CONCLUSIONS: Sepsis significantly affects the endothelial progenitor cell system, as reflected by increased EPC numbers, increased concentrations of proangiogenic mediators, and reduced proliferative capacity of the cells. This occurs independently from the frequency of dialysis and from patient survival. Increased serum levels of uric acid are possibly responsible for stronger EPC mobilization in sepsis patients with higher average creatinine levels.

Entities:  

Mesh:

Year:  2011        PMID: 21396100      PMCID: PMC3219359          DOI: 10.1186/cc10100

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


  42 in total

Review 1.  Endothelial progenitor cells: characterization and role in vascular biology.

Authors:  Carmen Urbich; Stefanie Dimmeler
Journal:  Circ Res       Date:  2004-08-20       Impact factor: 17.367

Review 2.  Endothelial progenitor cells functional characterization.

Authors:  Carmen Urbich; Stefanie Dimmeler
Journal:  Trends Cardiovasc Med       Date:  2004-11       Impact factor: 6.677

3.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

4.  Expression of CD34 in endothelial cells, hematopoietic progenitors and nervous cells in fetal and adult mouse tissues.

Authors:  G Lin; E Finger; J C Gutierrez-Ramos
Journal:  Eur J Immunol       Date:  1995-06       Impact factor: 5.532

5.  The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering.

Authors:  D R Sutherland; L Anderson; M Keeney; R Nayar; I Chin-Yee
Journal:  J Hematother       Date:  1996-06

6.  Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization.

Authors:  T Asahara; H Masuda; T Takahashi; C Kalka; C Pastore; M Silver; M Kearne; M Magner; J M Isner
Journal:  Circ Res       Date:  1999-08-06       Impact factor: 17.367

7.  Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization.

Authors:  Christopher Heeschen; Alexandra Aicher; Ralf Lehmann; Stephan Fichtlscherer; Mariuca Vasa; Carmen Urbich; Christiane Mildner-Rihm; Hans Martin; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Blood       Date:  2003-04-17       Impact factor: 22.113

8.  Isolation of putative progenitor endothelial cells for angiogenesis.

Authors:  T Asahara; T Murohara; A Sullivan; M Silver; R van der Zee; T Li; B Witzenbichler; G Schatteman; J M Isner
Journal:  Science       Date:  1997-02-14       Impact factor: 47.728

9.  Uremia causes endothelial progenitor cell deficiency.

Authors:  Kirsten de Groot; Ferdinand Hermann Bahlmann; Johanna Sowa; Jana Koenig; Jan Menne; Hermann Haller; Danilo Fliser
Journal:  Kidney Int       Date:  2004-08       Impact factor: 10.612

10.  Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin.

Authors:  Ferdinand H Bahlmann; Kirsten DeGroot; Thorsten Duckert; Eva Niemczyk; Elisabeth Bahlmann; Sascha M Boehm; Hermann Haller; Danilo Fliser
Journal:  Kidney Int       Date:  2003-11       Impact factor: 10.612

View more
  24 in total

Review 1.  Renoprotective approaches and strategies in acute kidney injury.

Authors:  Yuan Yang; Meifang Song; Yu Liu; Hong Liu; Lin Sun; Youming Peng; Fuyou Liu; Manjeri A Venkatachalam; Zheng Dong
Journal:  Pharmacol Ther       Date:  2016-04-22       Impact factor: 12.310

2.  Mobilization of circulating endothelial progenitor cells correlates with the clinical course of hantavirus disease.

Authors:  Ellen Krautkrämer; Stephan Grouls; David Hettwer; Neysan Rafat; Burkhard Tönshoff; Martin Zeier
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

3.  TLR4-SIRT3 Mechanism Modulates Mitochondrial and Redox Homeostasis and Promotes EPCs Recruitment and Survival.

Authors:  Xiaotian Wang; Weidong Yao; Meihui Wang; Junhui Zhu; Liang Xia
Journal:  Oxid Med Cell Longev       Date:  2022-07-04       Impact factor: 7.310

Review 4.  IMMUNE CELL PHENOTYPE AND FUNCTION IN SEPSIS.

Authors:  Thomas Rimmelé; Didier Payen; Vincenzo Cantaluppi; John Marshall; Hernando Gomez; Alonso Gomez; Patrick Murray; John A Kellum
Journal:  Shock       Date:  2016-03       Impact factor: 3.454

Review 5.  Mobilization of endothelial progenitor cells in sepsis.

Authors:  Ran Sun; Jiamin Huang; Bingwei Sun
Journal:  Inflamm Res       Date:  2019-11-22       Impact factor: 4.575

6.  Endothelial progenitor cells and a stromal cell-derived factor-1α analogue synergistically improve survival in sepsis.

Authors:  Hongkuan Fan; Andrew J Goodwin; Eugene Chang; Basilia Zingarelli; Keith Borg; Shuwen Guan; Perry V Halushka; James A Cook
Journal:  Am J Respir Crit Care Med       Date:  2014-06-15       Impact factor: 21.405

7.  Endothelial progenitors in sepsis: vox clamantis in deserto?

Authors:  Michael S Goligorsky
Journal:  Crit Care       Date:  2011-03-25       Impact factor: 9.097

8.  CD4+ lymphocyte adenosine triphosphate--a new marker in sepsis with acute kidney injury?

Authors:  Daniel Patschan; Malte Heeg; Maria Brier; Gunnar Brandhorst; Simon Schneider; Gerhard A Müller; Michael J Koziolek
Journal:  BMC Nephrol       Date:  2014-12-18       Impact factor: 2.388

Review 9.  Microparticles: markers and mediators of sepsis-induced microvascular dysfunction, immunosuppression, and AKI.

Authors:  Ana Carolina P Souza; Peter S T Yuen; Robert A Star
Journal:  Kidney Int       Date:  2015-02-18       Impact factor: 10.612

10.  Expanded endothelial progenitor cells mitigate lung injury in septic mice.

Authors:  Andreas Güldner; Tatiana Maron-Gutierrez; Soraia Carvalho Abreu; Debora Gonçalves Xisto; Alexandra Cristina Senegaglia; Patty Rose da Silva Barcelos; Johnatas Dutra Silva; Paulo Brofman; Marcelo Gama de Abreu; Patricia Rieken Macedo Rocco
Journal:  Stem Cell Res Ther       Date:  2015-11-26       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.